Relation between LRG1 and CD4+ T cells, cognitive impairment and neurological function in patients with acute ischemic stroke

Biomark Med. 2024 Jan;18(1):5-14. doi: 10.2217/bmm-2023-0674. Epub 2024 Feb 21.

Abstract

Objective: To assess the relationship between LRG1 and CD4+ T cells, cognitive impairment and neurological function in acute ischemic stroke (AIS). Methods: Plasma LRG1 was detected by ELISA in 175 patients with AIS at baseline, day (D) 1, D7, month (M) 1 and M3. Results: LRG1 was negatively related to Th2 and Treg cells and positively linked to Th17 (all p < 0.05). LRG1 increased from baseline to D1, then decreased until M3 (p < 0.001). LRG1 at each assessment point was increased in patients with cognitive impairment or poor neurological function at M3 versus those without (all p < 0.05). Conclusion: LRG1 is linked to decreased Th2 and Tregs, increased Th17, cognitive impairment and nonideal neurological function recovery in patients with AIS.

Keywords: CD4+ T cells; LRG1; acute ischemia stroke; cluster of differentiation 4+ T cells; cognitive impairment; leucine-rich alpha-2-glycoprotein1; neurological function.

MeSH terms

  • CD4-Positive T-Lymphocytes
  • Cognitive Dysfunction*
  • Enzyme-Linked Immunosorbent Assay
  • Glycoproteins
  • Humans
  • Ischemic Stroke* / complications
  • Stroke* / complications
  • T-Lymphocytes

Substances

  • LRG1 protein, human
  • Glycoproteins